Sentry Investment Management LLC lowered its position in shares of Mead Johnson Nutrition Company (NYSE:MJN) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,177 shares of the company’s stock after selling 658 shares during the period. Sentry Investment Management LLC’s holdings in Mead Johnson Nutrition Company were worth $1,263,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of MJN. Norges Bank bought a new position in Mead Johnson Nutrition Company during the fourth quarter worth approximately $102,498,000. Bank of New York Mellon Corp raised its position in Mead Johnson Nutrition Company by 0.5% in the first quarter. Bank of New York Mellon Corp now owns 1,429,953 shares of the company’s stock worth $127,382,000 after buying an additional 6,492 shares in the last quarter. Renaissance Technologies LLC raised its position in Mead Johnson Nutrition Company by 68.7% in the fourth quarter. Renaissance Technologies LLC now owns 1,025,700 shares of the company’s stock worth $72,579,000 after buying an additional 417,800 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in Mead Johnson Nutrition Company during the fourth quarter worth approximately $71,465,000. Finally, Marathon Asset Management LLP raised its position in Mead Johnson Nutrition Company by 47.3% in the first quarter. Marathon Asset Management LLP now owns 993,274 shares of the company’s stock worth $88,856,000 after buying an additional 319,043 shares in the last quarter. Institutional investors and hedge funds own 88.40% of the company’s stock.

Institutional Ownership by Quarter for Mead Johnson Nutrition Company (NYSE:MJN)

Mead Johnson Nutrition Company (NYSE:MJN) traded down 0.01% on Friday, reaching $89.98. 11,923,467 shares of the company’s stock traded hands. Mead Johnson Nutrition Company has a 52-week low of $69.25 and a 52-week high of $94.40. The firm has a market capitalization of $16.52 billion, a PE ratio of 28.27 and a beta of 1.57. The firm’s 50 day moving average price is $89.32 and its 200 day moving average price is $83.18.

Mead Johnson Nutrition Company (NYSE:MJN) last issued its earnings results on Thursday, April 27th. The company reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.01. Mead Johnson Nutrition Company had a net margin of 16.16% and a negative return on equity of 135.60%. The firm had revenue of $883.50 million during the quarter, compared to the consensus estimate of $911.63 million. During the same quarter in the prior year, the firm earned $0.87 earnings per share. The business’s quarterly revenue was down 8.2% on a year-over-year basis. On average, analysts predict that Mead Johnson Nutrition Company will post $3.20 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 5th. Shareholders of record on Tuesday, June 20th will be paid a $0.4125 dividend. This represents a $1.65 annualized dividend and a yield of 1.83%. The ex-dividend date is Friday, June 16th. Mead Johnson Nutrition Company’s payout ratio is presently 51.72%.

TRADEMARK VIOLATION NOTICE: This article was posted by Financial Market News and is the property of of Financial Market News. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.financial-market-news.com/2017/06/17/mead-johnson-nutrition-company-mjn-shares-sold-by-sentry-investment-management-llc.html.

MJN has been the topic of a number of research analyst reports. BMO Capital Markets reiterated a “hold” rating and set a $90.00 price objective on shares of Mead Johnson Nutrition Company in a research note on Thursday. BidaskClub upgraded shares of Mead Johnson Nutrition Company from a “sell” rating to a “hold” rating in a research note on Wednesday. Zacks Investment Research upgraded shares of Mead Johnson Nutrition Company from a “sell” rating to a “hold” rating in a research note on Wednesday, April 5th. Citigroup Inc. lowered shares of Mead Johnson Nutrition Company from a “buy” rating to a “neutral” rating in a research note on Monday, March 6th. Finally, Susquehanna Bancshares Inc set a $90.00 price objective on shares of Mead Johnson Nutrition Company and gave the company a “hold” rating in a research note on Saturday, April 1st. Two research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $84.83.

About Mead Johnson Nutrition Company

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Want to see what other hedge funds are holding MJN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mead Johnson Nutrition Company (NYSE:MJN).

Receive News & Ratings for Mead Johnson Nutrition Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Company and related companies with MarketBeat.com's FREE daily email newsletter.